These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Diguet E, Gross CE, Tison F, Bezard E. Exp Neurol; 2004 Sep; 189(1):1-4. PubMed ID: 15296829 [Abstract] [Full Text] [Related]
30. Minocycline and neurodegenerative diseases. Kim HS, Suh YH. Behav Brain Res; 2009 Jan 23; 196(2):168-79. PubMed ID: 18977395 [Abstract] [Full Text] [Related]
31. Minocycline: far beyond an antibiotic. Garrido-Mesa N, Zarzuelo A, Gálvez J. Br J Pharmacol; 2013 May 23; 169(2):337-52. PubMed ID: 23441623 [Abstract] [Full Text] [Related]
33. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Wang Q, Yan J, Chen X, Li J, Yang Y, Weng J, Deng C, Yenari MA. Exp Neurol; 2011 Jul 23; 230(1):27-34. PubMed ID: 20406638 [Abstract] [Full Text] [Related]
34. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. J Neurol Sci; 2005 Jun 15; 233(1-2):145-62. PubMed ID: 15896810 [Abstract] [Full Text] [Related]
37. Neuroprotection in progressive brain disorders. Djaldetti R, Lev N, Melamed E. Isr Med Assoc J; 2003 Aug 15; 5(8):576-80. PubMed ID: 12929297 [Abstract] [Full Text] [Related]